These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 20375654)

  • 1. An open-label, positron emission tomography study to assess adenosine A2A brain receptor occupancy of vipadenant (BIIB014) at steady-state levels in healthy male volunteers.
    Brooks DJ; Papapetropoulos S; Vandenhende F; Tomic D; He P; Coppell A; O'Neill G
    Clin Neuropharmacol; 2010; 33(2):55-60. PubMed ID: 20375654
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In Vivo Evaluation of
    Zhou X; Boellaard R; Ishiwata K; Sakata M; Dierckx RAJO; de Jong JR; Nishiyama S; Ohba H; Tsukada H; de Vries EFJ; Elsinga PH
    J Nucl Med; 2017 May; 58(5):762-767. PubMed ID: 28062599
    [No Abstract]   [Full Text] [Related]  

  • 3. Preclinical Evaluation and Quantification of
    Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
    J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occupancy of adenosine A
    Ishibashi K; Miura Y; Wagatsuma K; Toyohara J; Ishiwata K; Ishii K
    Neuropharmacology; 2018 Dec; 143():106-112. PubMed ID: 30253174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain adenosine A2A receptor occupancy by a novel A1/A2A receptor antagonist, ASP5854, in rhesus monkeys: relationship to anticataleptic effect.
    Mihara T; Noda A; Arai H; Mihara K; Iwashita A; Murakami Y; Matsuya T; Miyoshi S; Nishimura S; Matsuoka N
    J Nucl Med; 2008 Jul; 49(7):1183-8. PubMed ID: 18552135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Initial Evaluation of an Adenosine A
    Sakata M; Ishibashi K; Imai M; Wagatsuma K; Ishii K; Zhou X; de Vries EFJ; Elsinga PH; Ishiwata K; Toyohara J
    J Nucl Med; 2017 Sep; 58(9):1464-1470. PubMed ID: 28280214
    [No Abstract]   [Full Text] [Related]  

  • 7. In vivo evaluation of [
    Zhou X; Khanapur S; de Jong JR; Willemsen AT; Dierckx RA; Elsinga PH; de Vries EF
    J Cereb Blood Flow Metab; 2017 Feb; 37(2):577-589. PubMed ID: 26917190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling of brain D2 receptor occupancy-plasma concentration relationships with a novel antipsychotic, YKP1358, using serial PET scans in healthy volunteers.
    Lim KS; Kwon JS; Jang IJ; Jeong JM; Lee JS; Kim HW; Kang WJ; Kim JR; Cho JY; Kim E; Yoo SY; Shin SG; Yu KS
    Clin Pharmacol Ther; 2007 Feb; 81(2):252-8. PubMed ID: 17259948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine 2A receptor occupancy by tozadenant and preladenant in rhesus monkeys.
    Barret O; Hannestad J; Alagille D; Vala C; Tavares A; Papin C; Morley T; Fowles K; Lee H; Seibyl J; Tytgat D; Laruelle M; Tamagnan G
    J Nucl Med; 2014 Oct; 55(10):1712-8. PubMed ID: 25082853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JNJ-40255293, a novel adenosine A2A/A1 antagonist with efficacy in preclinical models of Parkinson's disease.
    Atack JR; Shook BC; Rassnick S; Jackson PF; Rhodes K; Drinkenburg WH; Ahnaou A; Te Riele P; Langlois X; Hrupka B; De Haes P; Hendrickx H; Aerts N; Hens K; Wellens A; Vermeire J; Megens AA
    ACS Chem Neurosci; 2014 Oct; 5(10):1005-19. PubMed ID: 25203719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization in humans of 18F-MNI-444, a PET radiotracer for brain adenosine 2A receptors.
    Barret O; Hannestad J; Vala C; Alagille D; Tavares A; Laruelle M; Jennings D; Marek K; Russell D; Seibyl J; Tamagnan G
    J Nucl Med; 2015 Apr; 56(4):586-91. PubMed ID: 25698783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of
    Lai TH; Schröder S; Toussaint M; Dukić-Stefanović S; Kranz M; Ludwig FA; Fischer S; Steinbach J; Deuther-Conrad W; Brust P; Moldovan RP
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A positron emission tomography study in healthy volunteers to estimate mGluR5 receptor occupancy of AZD2066 - estimating occupancy in the absence of a reference region.
    Kågedal M; Cselényi Z; Nyberg S; Raboisson P; Ståhle L; Stenkrona P; Varnäs K; Halldin C; Hooker AC; Karlsson MO
    Neuroimage; 2013 Nov; 82():160-9. PubMed ID: 23668965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of [(123)I]MNI-420: a novel single photon emission computed tomography radiotracer for imaging of adenosine 2A receptors in brain.
    Tavares AA; Batis J; Barret O; Alagille D; Vala C; Kudej G; Koren A; Cosgrove KP; Nice K; Kordower JH; Seibyl J; Tamagnan GD
    Nucl Med Biol; 2013 Apr; 40(3):403-9. PubMed ID: 23332393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of 11C-GSK189254 as a novel radioligand for the H3 receptor in humans using PET.
    Ashworth S; Rabiner EA; Gunn RN; Plisson C; Wilson AA; Comley RA; Lai RY; Gee AD; Laruelle M; Cunningham VJ
    J Nucl Med; 2010 Jul; 51(7):1021-9. PubMed ID: 20554726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Receptor occupancy of mirtazapine determined by PET in healthy volunteers.
    Smith DF; Stork BS; Wegener G; Jakobsen S; Bender D; Audrain H; Jensen SB; Hansen SB; Rodell A; Rosenberg R
    Psychopharmacology (Berl); 2007 Nov; 195(1):131-8. PubMed ID: 17653532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of 11C-MPDX and PET to study adenosine A1 receptor occupancy by nonradioactive agonists and antagonists.
    Paul S; Khanapur S; Sijbesma JW; Ishiwata K; Elsinga PH; Meerlo P; Dierckx RA; van Waarde A
    J Nucl Med; 2014 Feb; 55(2):315-20. PubMed ID: 24434292
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D₂-receptor occupancy measurement of JNJ-37822681, a novel fast off-rate D₂-receptor antagonist, in healthy subjects using positron emission tomography: single dose versus steady state and dose selection.
    Schmidt ME; de Boer P; Andrews R; Neyens M; Rossenu S; William Falteos D; Mannaert E
    Psychopharmacology (Berl); 2012 Dec; 224(4):549-57. PubMed ID: 22773165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of 7-amino-2-(2(3)-furyl)-5-phenylethylamino-oxazolo[5,4-d]pyrimidines as potential A2A adenosine receptor antagonists for positron emission tomography (PET).
    Holschbach MH; Bier D; Stüsgen S; Wutz W; Sihver W; Coenen HH; Olsson RA
    Eur J Med Chem; 2006 Jan; 41(1):7-15. PubMed ID: 16289482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain translocator protein occupancy by ONO-2952 in healthy adults: A Phase 1 PET study using [
    Frankle WG; Narendran R; Wood AT; Suto F; Himes ML; Kobayashi M; Ohno T; Yamauchi A; Mitsui K; Duffy K; Bruce M
    Synapse; 2017 Jul; 71(7):. PubMed ID: 28245513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.